ZS Whitepapers, Videos and Case Studies

ZS Experience Room™: Understanding Patient Treatment Decision-Making

Video

Watch the video for insights into ZS’s study on how unconscious biases influence patient treatment decisions.

Home vs. Away: Lessons on Customizing Your Go-to-Market Game Plan

Blogs

Medtech companies looking to expand abroad need to familiarize themselves with the local markets in order to compete against established players. Here’s how to get started building a truly global presence.

How United Gambled (and Lost) on a Lottery Incentive

Blogs

Does United’s quick abandonment of its lottery-based incentives plan mean that all lottery plans are bad? Here’s how companies can get it right.

Your Advisor Segmentation Is Broken. Here's How to Fix It.

Blogs

How to build advisor segmentation that drives real value.

The United Incentive Lottery: What Went Wrong

Blogs

Here’s what the travel industry can learn from United’s aborted attempt at switching its employee incentive program to a lottery system.

For Fund Launches, Slow and Steady Doesn't Win the Race

Blogs

Fund companies should plan dilligently for their fund launches, and focus their sales and marketing resources accordingly.

Collaboration in Clinical Operations: Three Takeaways From SCOPE 2018

Blogs

From cutting-edge technology to best practices, there was no shortage of innovative ideas at SCOPE 2018. Here are three observations from the conference, and a look at what’s ahead for clinical operations.

European Drug Pricing Alliances: Force or Farce?

Blogs

What does the evolution of European drug pricing alliances truly mean for drug prices around the world, and what are the implications for pharma companies?

How Understanding Unconscious Biases Can Improve Pharma Marketing

Blogs

Uncovering and understanding unconscious biases will result in improved communication between healthcare providers, pharma marketers and patients.

How the Johnson & Johnson Medical Devices Companies Are Responding to the Changing Healthcare Landscape

Blogs

For suppliers, it’s no longer enough to just make medical devices. We must bring both greater clinical and economic value to every point along the care pathway.